Skip to main content
. 2020 Feb 17;17:6. doi: 10.1186/s12987-020-0167-0

Table 3.

Silent period durations (SPs) and resting motor thresholds (RMTs) in iNPH patients and healthy controls

iNPH (n = 20) mean ± SD, range Control (n = 20) mean ± SD, range p-value
Upper limb SP (ms) 55.3 ± 17.7, 32.9–84.3 78.7 ± 16.1, 58.3–113.0 < 0.001
Upper limb RMT (%-MSO) 26.0 ± 4.4, 18.0–36.0 45.4 ± 12.2, 29.0–71.0 < 0.001
(V/m) 81.1 ± 13.0, 61.0–103.0 103.6 ± 23.6, 62.0–152.0 0.001
Lower limb RMT (%-MSO) 41.5 ± 7.6, 27.0–60.0 59.2 ± 13.9, 37.0–84.0 < 0.001

Significant differences are reported according to the Mann–Whitney U test for independent samples

MSO maximum stimulator output